Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis
- PMID: 10326224
- DOI: 10.1080/088800199277317
Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis
Abstract
The occurrence of Langerhans cell histiocytosis (LCH) and acute leukemia in one individual has rarely been observed. Despite few exceptions, two distinct patterns of association appear evident: acute lymphoblastic leukemia preceding LCH and LCH preceding acute nonlymphoblastic leukemia (ANLL). The latency of ANLL after the diagnosis of LCH is suggestive of a therapy-related process. This report describes two new cases in whom ANLL was diagnosed 7 years 8 months and 5 years 8 months after the start of initial treatment of disseminated recurrent LCH. Morphology showed blasts from FAB-type M4/M5 in the first patient, who died due to progression of leukemia. The second patient showed myelodysplastic syndrome (refractory anemia with excess of blasts in transformation; RAEB-t) and is now in remission from leukemia 3 years 11 months after allogeneic bone marrow transplantation. The review of a total of 26 patients with ANLL after LCH suggests that the disease has a poor prognosis and allogeneic BMT seems to be the treatment of choice.
Comment in
-
Etoposide and Langerhans cell histiocytosis: second malignancies, a second look.Pediatr Hematol Oncol. 1999 May-Jun;16(3):183-5. doi: 10.1080/088800199277236. Pediatr Hematol Oncol. 1999. PMID: 10326216 No abstract available.
Similar articles
-
Acute leukemia in association with Langerhans cell histiocytosis.Med Pediatr Oncol. 1994;23(2):81-5. doi: 10.1002/mpo.2950230204. Med Pediatr Oncol. 1994. PMID: 8202046
-
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.Ann Hematol. 2003 Jun;82(6):336-42. doi: 10.1007/s00277-003-0654-9. Epub 2003 May 1. Ann Hematol. 2003. PMID: 12728337 Clinical Trial.
-
Bone marrow transplantation for refractory Langerhans' cell histiocytosis.Haematologica. 1996 Sep-Oct;81(5):468-71. Haematologica. 1996. PMID: 8952163
-
Hematopoietic stem cell transplantation in Langerhans cell histiocytosis: case report and review of the literature.Pediatr Transplant. 2009 May;13(3):371-4. doi: 10.1111/j.1399-3046.2008.00989.x. Epub 2008 Jun 1. Pediatr Transplant. 2009. PMID: 18518907 Review.
-
Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis.Am J Dermatopathol. 2017 May;39(5):388-392. doi: 10.1097/DAD.0000000000000775. Am J Dermatopathol. 2017. PMID: 27759701 Review.
Cited by
-
Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine.Ann Hematol. 2013 Jan;92(2):267-8. doi: 10.1007/s00277-012-1555-6. Epub 2012 Aug 19. Ann Hematol. 2013. PMID: 22903510 Free PMC article. No abstract available.
-
Successful treatment of a case of acute myeloid leukemia following Langerhans cell histiocytosis in an adolescent: a case report and review of the literature.Int J Clin Exp Med. 2015 Feb 15;8(2):3024-6. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 25932277 Free PMC article.
-
Successful outcome of Langerhans cell histiocytosis complicated by therapy-related myelodysplasia and acute myeloid leukemia: a case report.Cases J. 2008 Aug 18;1(1):101. doi: 10.1186/1757-1626-1-101. Cases J. 2008. PMID: 18710527 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical